Evaluation of the effect of traditional Iranian medicine product on improvement of clinical menifestation of COVID -19

Phase 3

Recruiting

• Conditions: COVID-19.; Confirmed COVID-19; U07.1

• Registration Number: IRCT20101219005416N2
• Lead Sponsor: Kerman University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 21 April 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

The patients that confirmed COVID- 19 with specialist on the base of CT changing and pharyngeal specimen

Exclusion Criteria

Lack of informed consent
Pregnancy
Breastfeeding

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Response to the treatment (Significant clinical improvement). Timepoint: At baseline and daily. Method of measurement: According to the clinical, paraclinical and laboratory findings. Clinical improvement: normalization of the body temperature (=37.2 ° C), respiratory rate (=24 breaths per minute), oxygen saturation (> 94% at room temperature) and cough ; dyspnea ; headche and dirrhea that will measure on a qualitative scale based on the patient's report . Other outcome variables will measure during clinical examination.

Secondary Outcome Measures

Name	Time	Method
Duration of hospitalization. Timepoint: End of the treatment. Method of measurement: Patient's medical record.;Mortality. Timepoint: End of the treatment. Method of measurement: Patient's medical record (Clinical outcome).